These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 187508)

  • 21. Comparison of humoral neutralizing antibody response in rabbits, guinea pigs, and cattle vaccinated with epsilon and beta toxoids from Clostridium perfringens and C. botulinum types C and D toxoids.
    Silva ROS; Duarte MC; Oliveira Junior CA; de Assis RA; Lana AMQ; Lobato FCF
    Anaerobe; 2018 Dec; 54():19-22. PubMed ID: 30076896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potency testing Clostridium novyi-containing bacterins: comparison of immunologic response in guinea pigs and sheep.
    Macheak ME; Claus KD; Maloy SE
    Am J Vet Res; 1972 Jun; 33(6):1201-8. PubMed ID: 5022400
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin.
    Borrmann E; Schulze F; Cussler K; Hänel I; Diller R
    Vet Microbiol; 2006 Apr; 114(1-2):41-50. PubMed ID: 16361070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relation between the rabbit potency test and the response of sheep to sheep clostridial vaccines.
    Frerichs GN; Gray AK
    Res Vet Sci; 1975 Jan; 18(1):70-5. PubMed ID: 164058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on the antigenic structure of anatoxins of Clostridium perfringens, Cl. oedematiens, Cl. septicum and Cl. tetani by determining their fixation properties].
    Kalinichenko NF
    Mikrobiol Zh; 1966; 28(4):75-7. PubMed ID: 4297189
    [No Abstract]   [Full Text] [Related]  

  • 26. Demonstration of shared antigens in the genus Clostridium by an enzyme-linked immunosorbent assay.
    Poxton IR; Byrne MD
    J Med Microbiol; 1984 Apr; 17(2):171-6. PubMed ID: 6323714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The active and passive vaccination against Clostridium novyi and Clostridium tetani. 2].
    Klose F; Schallehn G
    Z Immunitatsforsch Allerg Klin Immunol; 1969 Nov; 138(5):480-7. PubMed ID: 4244400
    [No Abstract]   [Full Text] [Related]  

  • 28. Some problems concerning the assay of Clostridium chauvoei vaccine in laboratory animals.
    Knight PA; Kent J
    Dev Biol Stand; 1976; 32():143-50. PubMed ID: 1001828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Research in vitro on toxigenesis of Cl. tetani and Cl. botulinum].
    D'ARCA SIMONETTI A
    Nuovi Ann Ig Microbiol; 1959; 10():342-58. PubMed ID: 13813594
    [No Abstract]   [Full Text] [Related]  

  • 30. ANALYSES OF WOUND EXUDATES FOR CLOSTRIDIAL TOXINS.
    NOYES HE; PRITCHARD WL; BRINKLEY FB; MENDELSON JA
    J Bacteriol; 1964 Mar; 87(3):623-9. PubMed ID: 14127581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potency testing of Clostridium septicum bacterins in sheep and laboratory animals.
    Cardella MA; Kolbe DR
    Dev Biol Stand; 1976; 32():115-22. PubMed ID: 1001825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BotR/A and TetR are alternative RNA polymerase sigma factors controlling the expression of the neurotoxin and associated protein genes in Clostridium botulinum type A and Clostridium tetani.
    Raffestin S; Dupuy B; Marvaud JC; Popoff MR
    Mol Microbiol; 2005 Jan; 55(1):235-49. PubMed ID: 15612931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
    Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW
    Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some observations on the quality control testing of Clostridium chauvoei vaccines.
    Chandler HM
    Dev Biol Stand; 1976; 32():137-41. PubMed ID: 1001827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium oedematiens: observations on potency assaying.
    Macheak ME
    Dev Biol Stand; 1976; 32():103-12. PubMed ID: 1001824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use and standardization of multicomponent veterinary vaccines.
    Walker PD; Batty I
    Dev Biol Stand; 1986; 65():227-36. PubMed ID: 3549398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison between the official indirect method and the direct method of control of vaccines against sheep enterotoxemia].
    Dufrene M; Poul J; Gayot G
    Dev Biol Stand; 1976; 32():63-7. PubMed ID: 187512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A contribution on the active and passive vaccination against Clostridium novyi and Clostridium tetani].
    Klose F; Schallehn G
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Dec; 134(4):350-6. PubMed ID: 4233547
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunization against Clostridium perfringens cells elicits protection against Clostridium tetani in mouse model: identification of cross-reactive proteins using proteomic methodologies.
    Alam SI; Bansod S; Singh L
    BMC Microbiol; 2008 Nov; 8():194. PubMed ID: 19000325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The standardization of Cl. perfringens antigens and antisera.
    Jansen BC
    Dev Biol Stand; 1976; 32():35-44. PubMed ID: 187510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.